SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Karp David

(Last) (First) (Middle)
3780 BAYRIDGE AVENUE

(Street)
VANCOUVER A1 V7V 3J2

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
COUNTERPATH CORP [ CPAH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CEO and President
3. Date of Earliest Transaction (Month/Day/Year)
02/05/2020
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 31,995.1624 D
Common Shares 02/05/2020 A 75.2785(2) A $2.6568(3) 32,070.4409 D
Common Shares 02/05/2020 A 35.5833(2) A $2.8103(3) 32,106.0242 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options $13.1 06/12/2014(1) 12/12/2018 Common shares 20,000 20,000 D
Stock Options $13.1 12/12/2018 E 20,000 06/12/2014(1) 12/12/2018 Common 20,000 $13.1 0 D
Stock Options $2.4 07/14/2016(1) 07/14/2021 Common 20,000 40,000 D
Stock Options $2.89 12/14/2017(1) 12/14/2022 Common 50,000 90,000 D
Deferred Share Units (4) 12/14/2009 (4) Common 8,065.5(4) 8,064.5 D
Deferred Share Units (4) 06/18/2010 (4) Common 5,000(4) 13,064.5 D
Deferred Share Units (4) 03/10/2011 (4) Common 2,202.6(4) 15,267.1 D
Deferred Share Units (4) 07/25/2011 (4) Common 5,405.4(4) 20,672.5 D
Deferred Share Units (4) 07/19/2012 (4) Common 1,710.8(4) 22,383.3 D
Deferred Share Units (4) 07/25/2013(5) (4) Common 2,513.9(4) 24,897.2 D
Deferred Share Units (4) 07/11/2014(5) (4) Common 6,048.4(4) 30,945.6 D
Deferred Share Units (4) 07/17/2015(5) (4) Common 7,970.4(4) 38,916 D
Deferred Share Units (4) 07/14/2016 (4) Common 8,076 46,992 D
Deferred Share Units (4) 07/14/2017 (4) Common 13,376 60,368 D
Deferred Share Units (4) 07/26/2018 (4) Common 22,830 83,198 D
Deferred Share Units (4) 12/14/2018 (4) Common 40,000 123,198 D
Deferred Share Units (4) 11/04/2019 (4) Common 50,000 173,198 D
Explanation of Responses:
1. Options vest as to 12.5% after 6 months and 1/42 per month thereafter as per company plan.
2. These shares were purchased through an Employee Share Purchase Plan.
3. Canadian dollars.
4. Each deferred share unit is convertible into one common share of CounterPath Corporation at no additional cost. There is no expiry date. Deferred share units vest as to one-third of the number granted on each of the first, second and third anniversaries of the grant date.
5. The deferred share units vest one third over three years beginning on the first anniversary of the grant date.
/s/ David Karp 02/10/2020
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.